Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1984-11-21
|
pubmed:abstractText |
Plasma levels of beta-thromboglobin (beta-TH) and of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1-alpha, the stable metabolites of thromboxane A2 and prostacyclin, were determined by radioimmunoassay methods in eight patients with noninsulin-dependent diabetes before and after dietary treatment and after administration of the sulfonylurea drug glibenclamide. Blood examinations were performed when hyperglycemia was detected for the first time, four weeks after a dietary regimen was started, and four and eight weeks after glibenclamide treatment was begun. Drug treatment was instituted because, despite a suitable diet, patients' postprandial blood sugar was higher than 8 mmol/L (145 mg/dl). At the initial examination, elevated TXB2 and beta-TH levels indicating platelet hyperactivity and hyperglycemia were found. TXB2 and beta-TH levels decreased significantly after glibenclamide treatment was started, as did the blood glucose level. There was no change in 6-keto-PGF1-alpha. We interpret these results to indicate that diabetes is associated with hyperactivity of platelet aggregation and that control of blood glucose is important because a lower blood glucose level attenuates platelet hyperactivity. Whether the decrease in platelet hyperactivity is a direct result of the lowered blood sugar or reflects the influence of the drug treatment requires clarification.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/6-Ketoprostaglandin F1 alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Beta-Globulins,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxanes,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Thromboglobulin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0149-2918
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
636-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6206948-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:6206948-Adult,
pubmed-meshheading:6206948-Beta-Globulins,
pubmed-meshheading:6206948-Blood Glucose,
pubmed-meshheading:6206948-Blood Platelets,
pubmed-meshheading:6206948-Diabetes Mellitus, Type 2,
pubmed-meshheading:6206948-Female,
pubmed-meshheading:6206948-Glyburide,
pubmed-meshheading:6206948-Humans,
pubmed-meshheading:6206948-Male,
pubmed-meshheading:6206948-Middle Aged,
pubmed-meshheading:6206948-Platelet Aggregation,
pubmed-meshheading:6206948-Radioimmunoassay,
pubmed-meshheading:6206948-Thromboxane B2,
pubmed-meshheading:6206948-Thromboxanes,
pubmed-meshheading:6206948-beta-Thromboglobulin
|
pubmed:year |
1984
|
pubmed:articleTitle |
Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus.
|
pubmed:publicationType |
Journal Article
|